Number of patients | 201 |
Men/female, n | 150:51 |
Age, years ± SD | 74.9 ± 8.9 |
Diabetes duration, years ± SD | 11.4 ± 0.8 |
BMI, Kg/m2 ± SD | 26.7 ± 0.6 |
Smoking (current), n (%) | 103 (51.2) |
Smoking (former), n (%) | 68 (33.8) |
Never smoked, n (%) | 31 (15.4) |
Hypertension, n (%) | 146 (72.6) |
Hypercholesterolemia, n (%) | 109 (54.2) |
CAD, n (%) | 93 (46.3) |
CVD, n (%) | 99 (49.2) |
Oral antidiabetic agents, n (%) | 89 (44.3) |
Insulin, n (%) | 147 (73.1) |
ABI, ± SD | 0.6 ± 0.1 |
Rutherford II-4, n (%) | 109 (54.2) |
Rutherford III-5, n (%) | 92 (45.8) |
WIfI010, n (%) | 61 (30.3) |
WIfI020, n (%) | 51 (25.4) |
WIfI110, n (%) | 49 (24.4) |
WIfI120, n (%) | 40 (19.9) |
HbA1c, % ± SD | 8.9 ± 0.7 |
FBG, mg/dL ± SD | 127.9 ± 9.7 |
Total cholesterol, mg/dL ± SD | 218.9 ± 22.3 |
LDL cholesterol, mg/dL ± SD | 112.4 ± 15.4 |
Triglycerides, mg/dL ± SD | 172.5 ± 8.5 |
eGFR, mL/min/1.73m2 ± SD | 72.6 ± 10.5 |
HMGB-1, ng/mL ± SD | 5.9 ± 2.7 |